Additional Supporting Information may be found in the online version of this article.

hep26342-sup-0001-suppfig1.tif468KSupporting Information Figure 1
hep26342-sup-0002-supptab1.doc36KSupporting Table 1. Clinical characteristics (mean ± SD) of obese individuals according to liver phenotype with those study subjects without distinct phenotype.
hep26342-sup-0003-supptab2.doc62KSupporting Table 2. Liver histology in study subjects by NASH Clinical Research Network Scoring System Definitions and Scores (27).
hep26342-sup-0004-supptab3.doc27KSupporting Table 3. Clinical characteristics (mean ± SD) of obese individuals divided by the use of statins.
hep26342-sup-0005-supptab4.doc22KSupporting Table 4. Characteristics of all study subjects and subjects with available samples for liver sterol measurement and liver gene expression analysis (mean ± SD). There was no statistically significant difference between the groups.
hep26342-sup-0006-supptab5.doc21KSupporting Table 5. Spearman's correlations of serum total cholesterol, desmosterol, cholestenol and lathosterol with mRNA expression of SREBP1a and SREBP1c in liver tissue (n=80).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.